Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI

Cihangir Erem; İrfan Nuhoglu; Mustafa Kocak; Mustafa Yilmaz; Safiye Sipahi; Ozge Ucuncu; Halil Ersoz
June 2008
Endocrine (1355008X);Jun2008, Vol. 33 Issue 3, p270
Academic Journal
Abstract   Objective Growth hormone/insulin-like growth factor-1(GH/IGF-1) hypersecretion may influence risk factors contributing to the increased cardiovascular morbidity and mortality associated with acromegaly However, so far little is known about the impact of GH/IGF-1 on coagulation and fibrinolysis in acromegalic patients as possible risk factors for cardiovascular disease (CVD). To our knowledge, plasma tissue factor pathway inhibitor (TFPI) and thrombin-activatable fibrinolysis inhibitor (TAFI) levels in these patients have not been investigated. Therefore, the main purpose of this study was to evaluate the markers of endogenous coagulation/fibrinolysis, including TFPI and TAFI, and to investigate the relationships between GH/IGF-1 and these hemostatic parameters and serum lipid profile in patients with acromegaly. Research Methods and Procedures A total of 22 patients with active acromegaly and 22 age-matched healthy controls were included in the study. Fibrinogen, factors V, VII, VIII, IX, and X activities, von-Willebrand factor (vWF), antithrombin III (AT III), protein C, protein S, tissue plasminogen activator (t-PA), tissue plasminogen activator inhibitor-1 (PAI-1), TFPI and TAFI, as well as common lipid variables, were measured. The relationships between serum GH/IGF-1 and these hemostatic parameters were evaluated. Results Compared with the control subjects, fibrinogen, AT III, t-PA, and PAI-1 were increased significantly in patients with acromegaly (P P P P P P r: −0.514, P: 0.029 and r: −0.602, P: 0.014, respectively). There was also a negative correlation between insulin-like growth factor −1 (IGF-1) and PAI-1 (r: −0.455, P:0.045). Discussion We found some important differences in the hemostatic parameters between the patients with acromegaly and healthy controls. Increased fibrinogen, t-PA, PAI-1 and decreased protein S and TFPI in acromegalic patients may represent a potential hypercoagulable and hypofibrinolytic state, which might augment the risk for atherosclerotic and atherothrombotic complications. Thus, disturbances of the hemostatic system and dyslipidemia may contribute to the excess mortality due to CVD seen in patients with acromegaly.


Related Articles

  • Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. Erem, Cihangir; Ucuncu, Ozge; Yilmaz, Mustafa; Kocak, Mustafa; Nuhoglu, İrfan; Ersoz, Halil // Endocrine (1355008X);Dec2009, Vol. 36 Issue 3, p473 

    Abstract  Various abnormalities of coagulation-fibrinolytic system have been reported in patients with thyroid dysfunction. Several studies indicate that coagulation and fibrinolytic system is disturbed in the patients with hyperthyroidism. The levels of plasma thrombin-activatable...

  • Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity. Goedde, Martin F.; Grimbergen, Jos M.; Toet, Karin H.; Sitter, Thomas; Quax, Paul H.; Kooistra, Teake // Kidney International;Jul2001, Vol. 60 Issue 1, p117 

    Adenovirus-mediated transfer of the 39 kD receptor-associated protein increases fibrinolytic capacity. Background. The mesothelium has an important role in maintaining an adequate fibrinolytic capacity in the peritoneal cavity and thus in preventing the formation of fibrinous peritoneal...

  • Circling Coagulation Inhibitors in the Acquired Immunodeficiency Syndrome. Cohen, Alice J.; Philips, Terrence M.; Kessler, Craig M. // Annals of Internal Medicine;Feb86, Vol. 104 Issue 2, p175 

    Presents a study that identified abnormal coagulation profiles in patients with AIDS associated with opportunistic infections and malignancies. Elevation of activated partial thromboplastin times in patients; Presence of lupus-type anticoagulants characterized by rapid prolongations of the...

  • Coagulación y sangrado masivo: nuevos conceptos fisiopatológicos. Mauricio Gálvez Cárdenas, Kenny; Andrea Cortés López, Claudia // Medicina UPB;jul-dic2011, Vol. 30 Issue 2, p163 

    It is now accepted categorically that the main initiating event of blood coagulation is exposure of tissue factor (TF), which leads to the formation of the complex factor VIIa / TF that activates factors IX and X on the surface of cells expressing the FT, and finally the production of thrombin....

  • The role of prothrombin time (PT) in evaluating green pit viper (Cryptelytrops sp) bitten patients Pongpit, Jamrus; Limpawittayakul, Paweenrat; Juntiang, Jumlong; Akkawat, Benjaporn; Rojnuckarin, Ponlapat // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jul2012, Vol. 106 Issue 7, p415 

    Summary: Viper bites cause consumptive coagulopathy resulting in hypofibrinogenaemia. Whole-blood clotting time is a standard test used to assess bleeding risk. Prothrombin time (PT) and activated partial thromboplastin time (APTT) are better standardised assays that are widely available, but...

  • Effect of acrylonitrile on the procoagulant activity of rat lung. Bhooma, T.; Padmavathi, B.; Devaraj, S. // Bulletin of Environmental Contamination & Toxicology;Feb1992, Vol. 48 Issue 2, p321 

    The article presents a study which examines the procoagulant activity of the lung in rats after exposure to acrylonitrile. The study uses trypan blue exclusion, manual tilt method and standard human brain thromboplastin preparation to assess the effect of acrylonitrile in rat lung. Results show...

  • Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction. Schömig, Albert; Kastrati, Adnan; Dirschinger, Josef; Mehilli, Julinda; Schricke, Ullrich; Pache, Jürgen; Martinoff, Stefan; Neumann, Franz-Josef; Schwaiger, Markus // New England Journal of Medicine;08/10/2000, Vol. 343 Issue 6, p385 

    Background: Prevention of myocardial damage is the main goal of all reperfusion therapies in patients with acute myocardial infarction. The relative efficacy of various reperfusion strategies is under intensive investigation. We assessed whether coronary stenting combined with the blockade of...

  • Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause. Gebhart, J.; Laczkovics, C.; Posch, F.; Ay, C.; Reitter-Pfoertner, S.; Haslacher, H.; Muszbek, L.; Wolberg, A.; Pabinger, I. // Annals of Hematology;Aug2015, Vol. 94 Issue 8, p1301 

    In a large proportion of patients with mild bleeding disorders (MBDs) no diagnosis can be established by routine coagulation tests. We investigated whether alterations in plasma clot properties account for MBDs of unknown cause. Ninety-five patients with MBDs of unknown origin and 98 age- and...

  • A STUDY ON FIBRINOLYTIC MARKERS IN ACUTE STROKE PATIENTS IN HUSM. Zaidah, A. Wan; Zaharah, I. Siti; Rosline, H.; Madhavan, R.; Syalini, B. // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p76 

    Introduction: The fibrinolytic system plays an important role in preventing intra-vascular thrombosis. Previous researchers associate the stroke occurrence with the abnormality in fibrinolytic system. This study was done to compare the levels of three fibrinolytic markers i.e. plasminogen (plg),...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics